These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 11792760)

  • 41. The dilemmas of patient treatment for end-stage renal disease.
    Schmidt RW; Blumenkrantz M; Wiegmann TB
    Am J Kidney Dis; 1983 Jul; 3(1):37-47. PubMed ID: 6346866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increasing gender difference in the incidence of chronic dialysis therapy in Japan.
    Iseki K; Nakai S; Shinzato T; Nagura Y; Akiba T;
    Ther Apher Dial; 2005 Oct; 9(5):407-11. PubMed ID: 16202016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of management and treatment responses in haemodialysis patients from Tehran province, Iran.
    Mahdavi-Mazdeh M; Zamyadi M; Nafar M
    Nephrol Dial Transplant; 2008 Jan; 23(1):288-93. PubMed ID: 17965435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal disease in Colombia.
    Gómez RA
    Ren Fail; 2006; 28(8):643-7. PubMed ID: 17162422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The health care costs of diabetic nephropathy in the United States and the United Kingdom.
    Gordois A; Scuffham P; Shearer A; Oglesby A
    J Diabetes Complications; 2004; 18(1):18-26. PubMed ID: 15019595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A quarter century of medicare expenditures for ESRD.
    Eggers PW
    Semin Nephrol; 2000 Nov; 20(6):516-22. PubMed ID: 11111852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States? A hypothesis.
    Hawkins RG; Houston MC
    Am J Hypertens; 2005 Jun; 18(6):744-9. PubMed ID: 15925729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New and prevalent patients with end-stage renal disease in Canada. A portrait of the year 2000.
    Desmeules M; Schaubel D; Fenton SS; Mao Y
    ASAIO J; 1995; 41(2):230-3. PubMed ID: 7640434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Technical and economic strategies of maintenance dialysis in the UK and Nordic Countries.
    Cantaluppi A; East P
    J Nephrol; 2000; 13 Suppl 3():S10-5. PubMed ID: 11132025
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Worldwide demographics and future trends in end-stage renal disease.
    Port FK
    Kidney Int Suppl; 1993 Jun; 41():S4-7. PubMed ID: 8320944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective analysis of global costs for maintenance of patients with ESRD.
    Ploth DW; Shepp PH; Counts C; Hutchison F
    Am J Kidney Dis; 2003 Jul; 42(1):12-21. PubMed ID: 12830452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An analysis of dialysis training in the United States and Canada.
    Mehrotra R; Blake P; Berman N; Nolph KD
    Am J Kidney Dis; 2002 Jul; 40(1):152-60. PubMed ID: 12087573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HMOs and ESRD: a gloomy scenario.
    Steinman TI
    Nephrol News Issues; 1998 May; 12(5 Suppl):30, 33. PubMed ID: 9652298
    [No Abstract]   [Full Text] [Related]  

  • 54. Excerpts from the United States Renal Data System 1996 Annual Data Report.
    Am J Kidney Dis; 1996 Sep; 28(3 Suppl 2):S1-165. PubMed ID: 8804227
    [No Abstract]   [Full Text] [Related]  

  • 55. Forecast of the incidence, prevalence and burden of end-stage renal disease in Nanjing, China to the Year 2025.
    Sun L; Zou LX; Han YC; Huang HM; Tan ZM; Gao M; Ma KL; Liu H; Liu BC
    BMC Nephrol; 2016 Jun; 17(1):60. PubMed ID: 27295981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ESRD modality selection into the 21st century: the importance of non medical factors.
    Nissenson AR; Prichard SS; Cheng IK; Gokal R; Kubota M; Maiorca R; Riella MC; Rottembourg J; Stewart JH
    ASAIO J; 1997; 43(3):143-50. PubMed ID: 9152482
    [No Abstract]   [Full Text] [Related]  

  • 57. The economic burden of end-stage renal disease in Canada.
    Zelmer JL
    Kidney Int; 2007 Nov; 72(9):1122-9. PubMed ID: 17700643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 1997 U.S. Renal Data System Report. Incidence, prevalence rate showing signs of dropping in ESRD population.
    Nephrol News Issues; 1997 Sep; 11(9):36-8. PubMed ID: 9348871
    [No Abstract]   [Full Text] [Related]  

  • 59. The USRDS: what you need to know about what it can and can't tell us about ESRD.
    Foley RN; Collins AJ
    Clin J Am Soc Nephrol; 2013 May; 8(5):845-51. PubMed ID: 23124788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aging and ESRD demographics: consequences for the practice of dialysis.
    Williams ME; Sandeep J; Catic A
    Semin Dial; 2012; 25(6):617-22. PubMed ID: 23067122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.